Cancel

Links to sites outside of masspass.net are provided as a resource to the audiences. Please note that Takeda is not responsible or liable for any third-party website and the website may not be appropriate for all audiences. 

To stay on the current website, select “Cancel”


Continue

You are leaving Takeda.com

&#32593;&#25237;&#20449;&#35465;&#27604;&#36739;&#22909;&#30340;&#24179;&#21488;

&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;的标志

Takeda - Global

EPD-3055 OneTrust Cookie

EPD-3519 Schema Script

EPD-2855 GTM Script

EPD-4037 Matomo Tag Manager

EPD-4268 Cookie Script Hack

Find information and relevant documents on past and upcoming investor-related events, including the Annual Shareholders Meeting and broker conferences.

投资者活动与演讲|&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;制药

股票&#32593;&#25237;&#20449;&#35465;&#27604;&#36739;&#22909;&#30340;&#24179;&#21488; & 股东回报

Investor

# Investor Events



Divider Section Redesign

## Contents


#### Quarterly Results - Quarter 1 FY2024

(2024年7月31日)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results/)

*   [添加到日历](http://assets-dam.masspass.net/raw/upload/v1720569581/Global/Investor/events/2024/ics/quarterly-results-q1-fy2024-en.ics)

***

#### Quarterly Results - Quarter 2 FY2024

(2024年10月31日)

***


即将来临的事件

<div id="tab-3">#### TAK-861 Investor Call on Phase 2b Narcolepsy Type 1 Data

(2024年6月3日晚上7:30 - 8:30 CDT，晚上8:30 - 9:30 EDT)

*   [网络直播](http://www.irwebcasting.com/20240604/4/index.html)

*   [演讲](http://assets-dam.masspass.net/image/upload/v1717400991/Global/Investor/events/2024/tak-861-investor-call-en.pdf)

***

#### Quarterly Results - Quarter 4 FY2023

(2024年5月9日)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2023/)

***


过去事件

<div id="earnings-announcement-meetings--ir-events--broker-conferences">## Earnings Announcement Meetings / IR Events / Broker Conferences

#### 考恩44<sup>th</sup> 卫生保健会议

(美国东部时间2024年3月6日上午9:50 - 10:20)

*   本次活动已结束.

***

#### Quarterly Results - Quarter 3 FY2023

(2024年2月1日)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2023/)

***

#### 42nd Annual J.P. Morgan Healthcare Conference

(2024年1月8日太平洋标准时间下午5:15 - 5:55)

*   本次活动已结束.

***

#### Plasma-Derived Therapies Investor Event

(美国东部时间2023年12月5日下午6:00 - 7:00)

*   [网络直播](http://www.irwebcasting.com/20231206/3/index.html)
*   [演讲](http://assets-dam.masspass.net/image/upload/v1701756390/Global/Investor/events/2023/PDT_Presentation_2023_EN.pdf)

***

#### Jefferies London Healthcare Conference

(美国东部时间2023年11月14日凌晨4:00 - 4:25)

(格林尼治标准时间2023年11月14日上午9:00 - 9:25)

*   本次活动已结束.

***

#### Quarterly Results - Quarter 2 FY2023

(2023年10月26日)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2023/)

***

#### Morgan Stanley Healthcare Conference

(美国东部时间2023年9月11日下午3:35 - 4:05)

*   本次活动已结束.

***

#### Quarterly Results - Quarter 1 FY2023

(2023年7月27日)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2023/)

***

#### Quarterly Results - Quarter 4 FY2022

(2023年5月11日)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2022/)

***


2023财年(2023年4月- 2024年3月)

#### TAK-279 (TYK2 inhibitor) Investor Call on Phase 2b Psoriasis Data

(2023年3月18日)

*   [网络直播](http://www.irwebcasting.com/20230319/2/index.html)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1679175992/siteassets/system/investors/investor--events/TAK-279%20Investor%20Call_EN.pdf)

***

#### QDENGA Investor call

(2023年3月15日)

*   [网络直播](http://www.irwebcasting.com/20230316/2/index.html)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1679624806/siteassets/system/investors/investor--events/Qdenga%20Presentation_EN.pdf)

***

#### Cowen 43rd Health Care Conference

(2023年3月6日)

*   本次活动已结束.

***

#### Quarterly Results - Quarter 3 FY2022

(二零二三年二月二日)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2022/)

***

#### 41st Annual J.P. Morgan Healthcare Conference

(2023年1月9日)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1675192363/legacy-dotcom/siteassets/system/investors/investor--events/jpmhc23_presentation.pdf)

***

#### Conference call regarding acquisition of NDI-034858 From Nimbus Therapeutics

(2022年12月13日)

*   [演讲](http://sso.masspass.net/4af01e/siteassets/system/investors/investor--events/takeda-ir-call_en.pdf)

*   [网络直播](http://www.irwebcasting.com/20221214/3/index.html)

***

#### Jefferies London Healthcare Conference

(2022年11月15日)

*   本次活动已结束.

***

#### Quarterly Results - Quarter 2 FY2022

(2022年10月27日)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2022/)

***

#### Seminar: Investors and Analysts on Lysosomal Storage Diseases (LSD)

(2022年10月4日)

*   [演讲](http://sso.masspass.net/4a7c83/siteassets/system/investors/investor--events/en_lsd-ir-disease-seminar.pdf)

*   [网络直播](http://www.irwebcasting.com/20221004/2/index.html)

***

#### Morgan Stanley Healthcare Conference

(2022年9月12日)

*   本次活动已结束.

***

#### Quarterly Results - Quarter 1 FY2022

(2022年7月28日)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2022/)

***

#### Jefferies Healthcare Conference

(2022年6月9日)

*   本次活动已结束.

***

#### Quarterly Results - Quarter 4 FY2021

(2022年5月11日)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2021/)


2022财年(2022年4月- 2023年3月)

### 考恩42<sup>nd</sup> 卫生保健会议

(美国东部时间2022年3月8日下午2:50 - 3:20)

*   本次活动已结束.

***

### Seminar: Investors and Analysts on Short Bowel Syndrome (SBS) and Complex Crohn’s Perianal Fistulas (CPF)

(2022年2月24日下午1时)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1675192360/legacy-dotcom/siteassets/system/investors/investor--events/en_ir-disease-seminar_gi.pdf)

*   [网络直播](http://www.irwebcasting.com/20220224/2/index.html)

***

### Quarterly Results - Quarter 3 FY2021

(2022年2月3日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2021/)

***

### 40<sup>th </sup>年度J.P. 摩根医疗保健会议

(美国东部时间2022年1月10日下午4:30 - 5:10)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1675192362/legacy-dotcom/siteassets/system/investors/investor--events/jpmhc-presentation_2022.pdf)

***

### Takeda Management Call

(美国东部时间2022年1月10日下午6:00 - 7:00)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1675192360/legacy-dotcom/siteassets/system/investors/investor--events/en_takeda-mgmt-call_jan-11.pdf)

***

### Plasma-Derived Therapies Investor Event

(美国东部时间2021年11月17日下午5:30 - 7:30)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1662727524/legacy-dotcom/siteassets/system/investors/investor--events/IRDayPresentation_EN.pdf)

***

### Quarterly Results - Quarter 2 FY2021

(2021年10月28日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2021/)

***

### Quarterly Results - Quarter 1 FY2021

(2021年7月30日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2021/)

***

### Finance Investor Day

(美国东部时间2021年7月12日晚上7:00 - 9:00)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1675192361/legacy-dotcom/siteassets/system/investors/investor--events/finance-investor-day_en.pdf)

***

### Oncology Strategic Update Call

(美国东部时间2021年6月8日下午6:30 - 7:45)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1675192360/legacy-dotcom/siteassets/system/investors/investor--events/asco-2021-ir-event_en.pdf)

***

### 2021 Biopharma CEO Investor Forum

(美国东部时间2021年6月7日上午8:00 - 8:50)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1662727530/legacy-dotcom/siteassets/system/investors/investor--events/Takeda_CECP_CEO.pdf)

***

### Wave 1 Pipeline Market Opportunity Call Part 2

(美国东部时间2021年4月6日上午8:00 - 10:30)  

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1662727532/legacy-dotcom/siteassets/system/investors/investor--events/Wave1MarketEventPart2_EN.pdf)

*   [R\&D管道简介](http://assets-dam.masspass.net/raw/upload/v1662727534/legacy-dotcom/siteassets/system/what-we-do/research-and-development-rd-in-takeda/our-pipeline/PipelineFactsheet_Apr_2021.pdf)

***

### Quarterly Results - Quarter 4 FY2020

(2021年5月11日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2020/)

2021财年(2021年4月- 2022年3月)

### Growth and Emerging Markets Strategic Update Call

(美国东部时间2021年3月11日上午6:30 -8:15) 

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1662727532/legacy-dotcom/siteassets/system/investors/investor--events/GEM-IR-Day-Presentation.pdf)

***

### Seminar: Investors and Analysts on Takeda’s Japan Oncology Business and its oncology products and disease in Japan

(2021年2月25日下午1:00 -2:45)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1675192359/legacy-dotcom/siteassets/system/investors/investor--events/20210225_japan-_oncology-event_en.pdf)

***

### Quarterly Results - Quarter 3 FY2020

(2021年2月4日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2020/)

***

### World Conference on Lung Cancer (WCLC) Investor Event

(美国东部时间2021年1月29日下午5:00 -6:00)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1662727535/legacy-dotcom/siteassets/system/investors/investor--events/WCLC-2021-IR-Event.pdf)

***

### 39<sup>th </sup>年度J.P. 摩根医疗保健会议

(美国东部时间2021年1月11日下午5:20 -6:00)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1662727538/legacy-dotcom/siteassets/system/investors/investor--events/JPMHC2021.pdf)

***

### Wave 1 Pipeline Market Opportunity Call

(美国东部时间2020年12月8日下午5:00 -7:15)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1662727539/legacy-dotcom/siteassets/system/investors/investor--events/Wave1presentation_en.pdf)

***

### Quarterly Results - Quarter 2 FY2020

(2020年10月29日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2020/)

***

### Seminar: Investors and Analysts on Inflammatory Bowel Disease

(2020年9月2日下午1时)

*   [演讲](http://sso.masspass.net/4ab563/siteassets/system/investors/report/quarterlyannouncements/fy2020/20200902_ibd_en.pdf)

***

### Quarterly Results - Quarter 1 FY2020

(2020年7月31日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2020/)

***

### Seminar: Investors and Analysts on Hereditary Angioedema (HAE)

(2020年6月30日下午1时) 

*   [演讲](http://sso.masspass.net/4ab54d/siteassets/system/investors/report/quarterlyannouncements/fy2020/20200630_p01_en.pdf)

***

### Oncology Focused Investor Call

(2020年6月8日美国东部时间上午8:00 /日本标准时间晚上9:00)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1675192591/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2020/june-8-onc-investor-event-presentation-06.02.20-final.pdf)

***

### Quarterly Results - Quarter 4 FY2019

(2020年5月13日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2019/)

2020财年(2020年4月- 2021年3月)

### Quarterly Results - Quarter 3 FY2019

(2020年2月4日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2019/)

***

### 38<sup>th </sup>年度J.P. 摩根医疗保健会议

(2020年1月14日太平洋标准时间下午4:00 -4:55)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1662727548/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/JPMHC_2020.pdf)

***

### R\&东京的D日和血浆衍生疗法日

(2019年11月21日11:00am-5:00pm JST)

#### Plasma-Derived Therapies

*   血浆衍生疗法概述:Julie Kim，血浆衍生疗法事业部总裁

*   血浆衍生疗法\&D:克里斯托弗·莫拉比托，负责人，R\&D，血浆衍生疗法

*   [按此下载](http://assets-dam.masspass.net/raw/upload/v1675192579/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_tokyo-pdt-day_20191121.pdf) 

#### R\&D天

*   [点击下载幻灯片](http://assets-dam.masspass.net/raw/upload/v1675192582/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_tokyo-rd-day_all-slides_final_20191121.pdf)

*   [&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;:全球价值为基础，R\&d驱动型生物制药领导者: ](http://assets-dam.masspass.net/raw/upload/v1675192577/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_0---takeda_rdday_intro_final.pdf)克里斯托夫·韦伯，总裁 & 首席执行官

*   [将科学转化为高度创新的、改变生活的药物: ](http://assets-dam.masspass.net/raw/upload/v1675192576/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_1---andy-rd-day_final.pdf)安迪·普朗普，总裁，R\&D

*   [聚焦CAR-NK的肿瘤和细胞治疗: ](http://assets-dam.masspass.net/raw/upload/v1675192576/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_2---io-rd-day_final.pdf)克里斯·阿伦特，肿瘤药物研发部门主管

*   [聚焦肿瘤学机遇TAK-788: ](http://assets-dam.masspass.net/raw/upload/v1675192575/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_3---tak-788-rd-day_final.pdf)rachel Brake，肿瘤学全球项目负责人

*   [聚焦肿瘤学机遇: ](http://assets-dam.masspass.net/raw/upload/v1675192577/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_4---tak-924-rd-day_final.pdf)菲尔·罗兰兹，肿瘤治疗部门主管

*   [罕见疾病 & 基因疗法: ](http://assets-dam.masspass.net/raw/upload/v1675192577/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_5---rare-disease-rd-day_final.pdf)丹·柯伦，罕见病治疗部门的负责人

*   [Orexin2R激动剂: ](http://assets-dam.masspass.net/raw/upload/v1675192577/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_6---ox2r-rd-day_final.pdf)Deborah Hartman，神经科学全球项目负责人

*   [以乳糜泻为重点的胃肠道治疗领域 ](http://assets-dam.masspass.net/raw/upload/v1675192578/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/e_7---gi-rd-days_final.pdf)Asit Parikh，胃肠病治疗部门主管

*   [&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;R\&D管道叙事](http://assets-dam.masspass.net/raw/upload/v1675192589/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/takeda-rd-pipeline-narrative_20191114.pdf)

***

### Plasma-Derived Therapies Day in Covington, Georgia

(美国东部时间2019年11月15日11:15am-3:45pm)

*   [所有幻灯片](http://assets-dam.masspass.net/raw/upload/v1662727582/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/PDT_20191115.pdf)

*   血浆衍生疗法概述:Julie Kim，血浆衍生疗法事业部总裁

*   血浆衍生疗法\&D:克里斯托弗·莫拉比托，负责人，R\&D，血浆衍生疗法

*   科文顿网站介绍:Carlos Soto，科文顿网站负责人

***

### R\&登陆纽约

(美国东部时间2019年11月14日12:30 -4:00)

*   [所有幻灯片](http://assets-dam.masspass.net/raw/upload/v1675192578/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/all-slides_20191114_vf.pdf)

*   欢迎及开幕词:Sheelagh cauley - knopf，主任，R\&D全球投资组合策略

*   [&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;:全球价值为基础，R\&d驱动型生物制药领导者](http://assets-dam.masspass.net/raw/upload/v1675192572/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/0---christophe--slide-20191114_vf.pdf)克里斯托夫·韦伯，总裁 & 首席执行官

*   [将科学转化为高度创新的、改变生活的药物](http://assets-dam.masspass.net/raw/upload/v1662727595/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/1_Andy_20191114.pdf)Andy Plump，总裁，R\&D

*   [聚焦于CAR-NK的肿瘤和细胞疗法](http://assets-dam.masspass.net/raw/upload/v1662727596/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/2_IO_20191114.pdf)克里斯·阿伦特，肿瘤药物研发部主任

*   [聚焦肿瘤学机遇TAK-788](http://assets-dam.masspass.net/raw/upload/v1662727598/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/3_TAK788_20191114.pdf):肿瘤学全球项目负责人Rachael Brake

*   [聚焦肿瘤机会Pevonedistat](http://assets-dam.masspass.net/raw/upload/v1662727599/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/4_TAK924_20191114.pdf):菲尔·罗兰兹，肿瘤治疗部门主管

*   [罕见疾病 & 基因治疗](http://assets-dam.masspass.net/raw/upload/v1675192574/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/5_rare-disease_20191114_2.pdf):丹·柯伦，罕见病治疗部门负责人

*   [聚焦于Orexin2R激动剂](http://assets-dam.masspass.net/raw/upload/v1662727602/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/6_OX2R_20191114.pdf): Deborah Hartman，神经科学全球项目负责人

*   [以乳糜泻为重点的胃肠道治疗领域](http://assets-dam.masspass.net/raw/upload/v1662727604/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/7_GI_20191114.pdf): Asit Parikh，胃肠道治疗部门主管

*   [&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;R\&D管道叙事](http://assets-dam.masspass.net/raw/upload/v1675192589/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/takeda-rd-pipeline-narrative_20191114.pdf)

***

### Quarterly Results - Quarter 2 FY2019

(2019年10月31日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2019/)

***

### IR meeting with analysts and investors with Julie Kim, President of Takeda's Plasma-Derived Therapies Business Unit

(2019年10月10日举行)

*   本次活动已结束.

***

### Morgan Stanley Healthcare Conference

(美国东部时间2019年9月10日举行)

*   本次活动已结束.

***

### Quarterly Results - Quarter 1 FY2019

(2019年7月31日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2019/)

***

### IR Seminar “Plasma-Derived Therapies Business”

(2019年7月12日举行)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1675192570/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2019/20190712-ir-presentation-on-pdt_final_e.pdf)

***

### Quarterly Results - Quarter 4 FY2018

(2019年5月14日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2018/)

2019财年(2019年4月- 2020年3月)

### Quarterly Results - Quarter 3 FY2018

(2019年2月1日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2018/)

***

### 37<sup>th </sup>年度J.P. 摩根医疗保健会议

(2019年1月8日举行，太平洋标准时间)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1662727541/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/fy2018-q2-announcements/JPMHC2019-E.pdf)

***

### Meeting regarding Acquisition of Shire plc by Takeda

(2019年1月7日举行) 

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1675192566/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/fy2018-q2-announcements/shire-deal-close-announcement_en.pdf):一个全球性的，基于价值的，R&d驱动的生物制药领导者

*   [更多关于&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;收购夏尔公司的细节.](http://sso.masspass.net/investors/offer-for-shire/)

***

### Quarterly Results - Quarter 2 FY2018

(2018年10月31日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2018/)

***

### &#21313;&#22823;&#32593;&#36172;&#24179;&#21488;的R&D投资者日(波士顿)

(2018年10月11日)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1662727546/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/0_FULL_DECK_Boston_E.pdf)兑现我们的承诺&D视觉

*   安迪·普朗普，首席医疗和科学官

    *   [肿瘤学](http://assets-dam.masspass.net/raw/upload/v1662727548/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/1_Oncology_Boston_E.pdf)

    *   [胃肠病学](http://assets-dam.masspass.net/raw/upload/v1662727549/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/2_GI_DECK_Boston_E.pdf)

    *   [神经科学](http://assets-dam.masspass.net/raw/upload/v1662727551/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/3_NS_DECK_Boston_E.pdf)

    *   [疫苗](http://assets-dam.masspass.net/raw/upload/v1662727552/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/4_VBU_DECK_Boston_E.pdf)

***

### &#21313;&#22823;&#32593;&#36172;&#24179;&#21488;的R&D投资者日(东京)

(2018年9月27日)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1662727554/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/0_FULLDECK_E_rd_day.pdf)兑现我们的承诺&D视觉

*   安迪·普朗普，首席医疗和科学官

    *   [肿瘤学](http://assets-dam.masspass.net/raw/upload/v1662727555/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/1_ONCOLOGY_E.pdf)

    *   [胃肠病学](http://assets-dam.masspass.net/raw/upload/v1662727557/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/2_GI_E.pdf)

    *   [神经科学](http://assets-dam.masspass.net/raw/upload/v1662727558/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/3_NS_E.pdf)

    *   [疫苗](http://assets-dam.masspass.net/raw/upload/v1662727559/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/4_VACCINE_E.pdf)

    *   [湘南iPark](http://assets-dam.masspass.net/raw/upload/v1662727560/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/5_IPARK_E.pdf)

***

### Quarterly Results - Quarter 1 FY2018

(2018年7月31日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2018/)

***

### Quarterly Results - Quarter 4 FY2017

(2018年5月14日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2017/)

***

### Conference Call Regarding Proposed Acquisition of Shire plc by Takeda

(2018年5月8日至9日举行)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1675192569/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2018/takeda-to-acquire-shire-accelerating-takeda_s-transformation-to-deliver-more-for-patients.pdf):&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;收购shire——加速&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;转型，为患者提供更多服务



2018财年(2018年4月- 2019年3月)

### Quarterly Results - Quarter 3 FY2017

(2018年2月1日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2017/)

***

### 36<sup>th </sup>年度J.P. 摩根医疗保健会议

(于太平洋标准时间2018年1月8日举行)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1662727540/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2017/36th-annual-j.p.-morgan-healthcare-conference-held-on-january-8-2018-pst/qr2017_q3_p01_en.pdf)

***

### Jefferies 2017 Global Healthcare Conference

(2017年11月16日，10:00 GMT)

*   本次活动已结束.

***

### Quarterly Results - Quarter 2 FY2017

(2017年11月1日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2017/)

***

### Quarterly Results - Quarter 1 FY2017

(2017年7月28日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2017/)

***

### UBS Global Healthcare Conference

(美国东部时间2017年5月23日9:30发布)

*   本次活动已结束.

***

### Quarterly Results - Quarter 4 FY2016

(2017年5月10日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2016/)

2017财年(2017年4月- 2018年3月)

### Quarterly Results - Quarter 3 FY2016

(2017年2月1日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2016/)

***

### Conference Call on the Acquisition of ARIAD Pharmaceuticals

(2017年1月10日发布)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1675192549/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2016/conference-call-on-the-acquisition-of-ariad-pharmaceuticals-released-on-january-10-2017/takeda-to-acquire-ariad-pharmaceuticals.pdf)

***

### 35<sup>th</sup>年度J.P. 摩根医疗保健会议

(2017年1月9日举行)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1675192549/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2016/35thannual-j.p.-morgan-healthcare-conference-held-on-january-9-2017/j.p.-morgan-healthcare-conference-presentation.pdf)

***

### Quarterly Results - Quarter 2 FY2016

(2016年10月28日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2016/)

***

### Quarterly Results - Quarter 1 FY2016

(2016年7月29日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2016/)

***

### Takeda IR Day

(2016年6月9日举行)

1.  [&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;肿瘤: ](http://assets-dam.masspass.net/raw/upload/v1675192554/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2016/takeda-ir-day-held-on-june-9-2016/1.-takeda-oncology.pdf)Christophe Bianchi，全球肿瘤业务部总裁

2.  [专注的世界级R&D创新的新途径: ](http://assets-dam.masspass.net/raw/upload/v1675192555/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2016/takeda-ir-day-held-on-june-9-2016/2.-focused-world-class-r_d.pdf)安德鲁·普朗普，首席医疗官 & 科学官

***

### Quarterly Results - Quarter 4 FY2015

(2016年5月10日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2015/)

2016财年(2016年4月- 2017年3月)

### Quarterly Results - Quarter 3 FY2015

(2016年2月3日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2015/)

***

### 34th Annual J.P. Morgan Healthcare Conference

(2016年1月12日举行)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1662727538/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2015/34th-annual-j.p.-morgan-healthcare-conference-held-on-january-12-2016/qr2015_q3_p01_en.pdf)

***

### Quarterly Results - Quarter 2 FY2015

(2015年10月30日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2015/)

***

### Quarterly Results - Quarter 1 FY2015

(2015年7月30日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2015/)

***

### Quarterly Results - Quarter 4 FY2014

(2015年5月15日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2014/)

2015财年(2015年4月- 2016年3月)

### Takeda IR Event: A Global Leader in Gastroenterology

(2015年3月9日举行)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1662727534/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2014/takeda-ir-event--a-global-leader-in-gastroenterology-held-on-march-9-2015/qr2014_q3_p_en.pdf)

***

### Quarterly Results - Quarter 3 FY2014

(2015年2月5日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2014/)

***

### 33<sup>rd</sup> 年度J.P. 摩根医疗保健会议

(2015年1月13日举行)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1662727535/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2014/33rd-annual-j.p.-morgan-healthcare-conference-held-on-january-13-2015/qr2014_q3_e01_en.pdf)

***

### Quarterly Results - Quarter 2 FY2014

(2014年10月30日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2014/)

***

### Quarterly Results - Quarter 1 FY2014

(2014年8月1日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2014/)

***

### Quarterly Results - Quarter 4 FY2013

(2014年5月8日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2013/)

2014财年(2014年4月- 2015年3月)

### Quarterly Results - Quarter 3 FY2013

(2014年2月5日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2013/)

***

### 32<sup>nd</sup> 年度J.P. 摩根医疗保健会议

(2014年1月13日举行)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1675192534/legacy-dotcom/siteassets/system/investors/report/quarterlyannouncements/fy2013/32nd-annual-j.p.-morgan-healthcare-conference-held-on-january-13-2014/j.p.-morgan-healthcare-conference-presentation.pdf)

***

### Quarterly Results - Quarter 2 FY2013

(2013年10月31日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2013/)

***

### Quarterly Results - Quarter 1 FY2013

(2013年7月31日举行)

*   [阅读更多](http://sso.masspass.net/investors/financial-results/quarterly-results-2013/)

2013财年(2013年4月- 2014年3月)

## Event Archive



### 148th Ordinary General Meeting of Shareholders (June 26, 2024)

*   [第148届股东大会召开通知](http://assets-dam.masspass.net/image/upload/v1716784771/Global/Investor/events/shareholders-meetings/2024/sm_148_01_en.pdf)

*   [其他以电子方式提供的项目](http://assets-dam.masspass.net/image/upload/v1716771549/Global/Investor/events/shareholders-meetings/2024/sm_148_02_en.pdf)

*   [主席克里斯托夫·韦伯的留言 & 首席执行官](http://sso.masspass.net/investors/events/shareholder-letter-2024)

*   [&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;的高管薪酬概述](http://assets-dam.masspass.net/image/upload/v1716782703/Global/Investor/events/shareholders-meetings/2024/sm_148_04_en.pdf)

*   [2023财年第四季度财务业绩](http://sso.masspass.net/investors/financial-results/quarterly-results/)

*   [饭岛雅美发表声明, &#21313;&#22823;&#32593;&#36172;&#24179;&#21488;董事会会议主席, 回应机构股东服务公司.第148届股东大会前的投票建议](http://assets-dam.masspass.net/image/upload/v1717730187/Global/Investor/events/shareholders-meetings/2024/iss-reactive-statement_en.pdf)

*   [对第一百四十八届股东大会召开通知的部分更正](http://assets-dam.masspass.net/image/upload/v1717986546/Global/Investor/events/shareholders-meetings/2024/sm_148_05_en.pdf)

*   [演讲](http://assets-dam.masspass.net/image/upload/v1719479941/Global/Investor/events/shareholders-meetings/2024/sm_148_07_en.pdf)

*   [第一百四十八届股东大会决议通知](http://assets-dam.masspass.net/image/upload/v1718759459/Global/Investor/events/shareholders-meetings/2024/sm_148_06_en.pdf)

*   [第148届股东大会行使表决权的结果](http://assets-dam.masspass.net/image/upload/v1719808017/Global/Investor/events/shareholders-meetings/2024/sm_148_08_en.pdf)

*   [第148届股东大会(录像)](http://bcove.video/3XNRk4n)


<div id="annual-shareholders-meetings">## Annual Shareholders Meetings</div>


*   [第147届股东大会召开通知](http://assets-dam.masspass.net/image/upload/v1687414710/Global/Investor/events/shareholders-meetings/2023/sm_147_01-2_en.pdf)

*   [其他以电子方式提供的项目](http://assets-dam.masspass.net/raw/upload/v1685345588/Global/Investor/events/shareholders-meetings/2023/sm_147_02_en.pdf)

*   [主席克里斯托夫·韦伯的留言 & 首席执行官](http://assets-dam.masspass.net/raw/upload/v1685345588/Global/Investor/events/shareholders-meetings/2023/sm_147_03_en.pdf)

*   [&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;的高管薪酬概述](http://assets-dam.masspass.net/raw/upload/v1685345588/Global/Investor/events/shareholders-meetings/2023/sm_147_04_en.pdf)

*   [FY2022第四季度财务业绩](http://sso.masspass.net/investors/financial-results/quarterly-results/)

*   [对第147次股东大会召开通知的部分更正](http://assets-dam.masspass.net/image/upload/v1687409671/Global/Investor/events/shareholders-meetings/2023/Notice_of_Amendment_to_be_posted_on_the_WEB.pdf)

*   [演讲](http://assets-dam.masspass.net/image/upload/v1688013747/Global/Investor/events/shareholders-meetings/2023/sm_147_07_en.pdf)

*   [决议公告](http://assets-dam.masspass.net/image/upload/v1687488561/Global/Investor/events/shareholders-meetings/2023/sm_147_06_en.pdf)

*   [行使表决权的结果](http://assets-dam.masspass.net/image/upload/v1688114712/Global/Investor/events/shareholders-meetings/2023/sm_147_08_en.pdf)


第147次股东大会(2023年6月28日)

*   [营业报告(中期)](http://assets-dam.masspass.net/image/upload/v1701060648/Global/Investor/events/shareholders-meetings/2023/br147_mid_en.pdf)



第147次中期报告

*   [召集通知](http://assets-dam.masspass.net/raw/upload/v1662727586/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_01_en_1.pdf)

*   [通过互联网披露的有关召开股东大会通知的事项](http://assets-dam.masspass.net/raw/upload/v1662727587/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_02_en.pdf)

*   [主席克里斯托夫·韦伯的留言 & 首席执行官](http://assets-dam.masspass.net/raw/upload/v1662725889/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_03_en_1.pdf)

*   [&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;的高管薪酬概述](http://assets-dam.masspass.net/raw/upload/v1662727590/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_04_en.pdf)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1662727593/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_07_en.pdf)

*   [决议公告](http://assets-dam.masspass.net/raw/upload/v1662727594/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_05_en.pdf)

*   [行使表决权的结果](http://assets-dam.masspass.net/raw/upload/v1662727595/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_06_en.pdf)

第146届股东大会(2022年6月29日)

*   [营业报告(中期)](http://assets-dam.masspass.net/raw/upload/v1669795726/legacy-dotcom/siteassets/system/investors/report/business/br146_mid_en.pdf)



第146次中期报告

*   [召集通知](http://assets-dam.masspass.net/raw/upload/v1662727596/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_01_en.pdf)

*   [通过互联网披露的有关召开股东大会通知的事项](http://assets-dam.masspass.net/raw/upload/v1662727597/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_02_en.pdf)

*   [主席克里斯托夫·韦伯的留言 & 首席执行官](http://assets-dam.masspass.net/raw/upload/v1662727599/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_03_en.pdf)

*   [&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;的高管薪酬概述](http://assets-dam.masspass.net/raw/upload/v1662727600/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_04_en_2.pdf)

*   [对第145届股东大会召开通知的部分更正](http://assets-dam.masspass.net/raw/upload/v1662727601/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_05_en.pdf)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1662727602/legacy-dotcom/siteassets/system/investors/shareholders-meetings/FY2021_GSM_28-June-2021_vF.pdf)

*   [决议公告](http://assets-dam.masspass.net/raw/upload/v1662727603/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_06_en.pdf)

*   [行使表决权的结果](http://assets-dam.masspass.net/raw/upload/v1662727604/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_145_07_en.pdf)

第145届股东大会(2021年6月29日)

*   [营业报告(中期)](http://assets-dam.masspass.net/raw/upload/v1662727594/legacy-dotcom/siteassets/system/investors/report/business/br145_mid_en.pdf)



第145次中期报告

*   [召集通知](http://assets-dam.masspass.net/raw/upload/v1662727605/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_144_01_en.pdf)

*   [通过互联网披露的有关召开股东大会通知的事项](http://assets-dam.masspass.net/raw/upload/v1662727607/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_144_02_en.pdf)

*   [主席克里斯托夫·韦伯的留言 & 首席执行官](http://assets-dam.masspass.net/raw/upload/v1662727608/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_144_03_en.pdf)

*   [&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;的高管薪酬概述](http://assets-dam.masspass.net/raw/upload/v1662727609/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_144_04_en.pdf)

*   [对《&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;》通过互联网披露的事项进行部分更正](http://sso.masspass.net/4ab49c/siteassets/system/investors/shareholders-meetings/e_notice-of-amendment-to-be-posted-on-the-web.pdf)

*   [第144届股东大会，Christophe Weber](http://assets-dam.masspass.net/raw/upload/v1675192637/legacy-dotcom/siteassets/system/investors/shareholders-meetings/cw2020_15min_gsm_presentation_1806.pdf)

*   [决议公告](http://sso.masspass.net/4ab49c/siteassets/system/investors/shareholders-meetings/sm_144_05-en.pdf)

*   [行使表决权的结果](http://sso.masspass.net/4ab49f/siteassets/system/investors/shareholders-meetings/sm_144_06_en.pdf)

第144次股东大会(2020年6月24日)

*   [营业报告(中期)](http://assets-dam.masspass.net/raw/upload/v1662727596/legacy-dotcom/siteassets/system/investors/report/business/br144_mid_en.pdf)



第144次中期报告

*   [召集通知](http://assets-dam.masspass.net/raw/upload/v1662727611/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_01_en.pdf)

*   [通过互联网披露的有关召开股东大会通知的事项](http://assets-dam.masspass.net/raw/upload/v1662727612/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_02_en.pdf)

*   [主席克里斯托夫·韦伯的留言 & 首席执行官](http://assets-dam.masspass.net/raw/upload/v1662727613/legacy-dotcom/siteassets/system/investors/shareholders-meetings/letter_1905_en.pdf)

*   [对第一百四十三届股东大会召开通知的部分更正](http://assets-dam.masspass.net/raw/upload/v1662727613/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_03_en.pdf)

*   [第一百四十三届股东大会提案补充材料](http://assets-dam.masspass.net/raw/upload/v1662727614/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_04_en.pdf)

*   [&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;对高管薪酬计划的修改总结及未来考虑](http://assets-dam.masspass.net/raw/upload/v1662727616/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_05_en.pdf)

*   [&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;建议在第143届股东大会上投票表决&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;的提案](http://assets-dam.masspass.net/raw/upload/v1675192638/legacy-dotcom/siteassets/system/investors/shareholders-meetings/shareholder-engagement-response-e-final-clean-v3.pdf)

*   [对奥巴马总统领导能力的信心声明. 克里斯托夫·韦伯和坂根雅弘对第143届股东大会提案的评论, &#21313;&#22823;&#32593;&#36172;&#24179;&#21488;董事会主席会议](http://assets-dam.masspass.net/raw/upload/v1675192638/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sakane-san-message_e-with-attachment.pdf)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1662727621/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_p01_en.pdf)

*   [2018财年综合财务业绩和2019财年指引](http://assets-dam.masspass.net/raw/upload/v1662727622/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_p02_en.pdf)

*   [决议公告](http://assets-dam.masspass.net/raw/upload/v1675192644/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_06-en.pdf)

*   [行使表决权的结果](http://assets-dam.masspass.net/raw/upload/v1662727623/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_143_07_en.pdf)

第143届股东大会(2019年6月27日)

*   [营业报告(中期)](http://assets-dam.masspass.net/raw/upload/v1662727597/legacy-dotcom/siteassets/system/investors/report/business/br143_mid_en.pdf)



第143次中期报告

*   [召集通知](http://assets-dam.masspass.net/raw/upload/v1662727624/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_2018ext_01_en.pdf)

*   [主席克里斯托夫·韦伯的留言 & 首席执行官，关于收购夏尔公司](http://assets-dam.masspass.net/raw/upload/v1662727625/legacy-dotcom/siteassets/system/investors/shareholders-meetings/letter_1811_en.pdf)

*   [对临时股东大会召开通知所附参考文件的部分更正](http://assets-dam.masspass.net/raw/upload/v1662727626/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_2018ext_1115_en.pdf)

*   [演讲](http://assets-dam.masspass.net/raw/upload/v1662727628/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_2018ext_1210_01_en.pdf)

*   [决议公告](http://assets-dam.masspass.net/raw/upload/v1662727629/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_2018ext_1205_en.pdf)

*   [行使表决权的结果](http://assets-dam.masspass.net/raw/upload/v1662727630/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_2018ext_1210_02_en.pdf)

*   [了解更多关于夏尔的报价](/investors/overview/offer-for-shire)



临时股东大会(2018年12月5日)

## 过往股东活动 & 报告



#### Online information session for retail investors: "Committed to Growth & 股东回报" (in Japanese only)

2024年2月22日JST晚上7:45 - 8:30

*   [网络直播](http://api01-platform.stream.co.jp/apiservice/plt3/NTk0NA%3d%3d%23NTI3Mg%3d%3d%23280%23168%23b%233FE2A0D9E400%23MDoyOjc6YTpmOzEwOzEwOzEw%23)
*   [演讲](http://assets-dam.masspass.net/image/upload/v1710384814/Global/Investor/events/2024/presentation_02222024.pdf)

***

#### Information session for retail investors: "Better health for people, Brighter future for the world"

2023年2月22日

*   [演讲](http://assets-dam.masspass.net/image/upload/v1678160771/legacy-dotcom/siteassets/system/investors/investor--events/20230222_retail%20investor%20event_presentation.pdf)

***

<div id="retail-investor-events">## Retail Investor Events</div>





了解最新的财务结果, 公司里程碑，了解我们如何履行对患者的承诺, 我们的人民和地球

## Sign up for our investors newsletter



公司最新最重要的财务<a href='http://sso.masspass.net'>&#32593;&#25237;&#20449;&#35465;&#27604;&#36739;&#22909;&#30340;&#24179;&#21488;</a>